Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | BRD2 | P25440 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12252009 | 0.81 | — | — | |
| SCHEMBL11607389 | 0.75 | KMT2A (0.35) | KMT2ACRBNBRD4BRD2ADRA2C | |
| Hydrochloric Acid SCHEMBL11349959 | 0.73 | KMT2A (0.33) | KMT2ACRBNBRD4BRD2ADRA2C | |
| Bromide SCHEMBL11607704 | 0.73 | KMT2A (0.33) | KMT2ACRBNBRD4BRD2ADRA2C | |
| SCHEMBL2238464 | 0.72 | — | — | |
| SCHEMBL15247796 | 0.69 | — | — | |
| SCHEMBL9122897 | 0.69 | KMT2A (0.35) | KMT2ACRBNBRD4BRD2ADRA2C | |
| SCHEMBL13710828 | 0.69 | — | — | |
| SCHEMBL2235528 | 0.69 | BRD4 (0.41) | BRD4BRD2 | |
| SCHEMBL228923 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2248792-B1 | PROCESS FOR PRODUCTION OF OXYGEN-CONTAINING ORGANIC COMPOUND | DAICEL CHEM (JP) | 2013-11-27 | — | — | EP | disclosed |
| US-8410308-B2 | Process for production of oxygen-containing organic compound | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2013-04-02 | — | — | US | disclosed |
| EP-2096097-B1 | METHOD FOR PRODUCING OXIDATION PRODUCT OF CYCLOALKANE | DAICEL CHEM (JP) | 2012-08-22 | — | — | EP | disclosed |
| US-7994330-B2 | Oxidizing p-xylene to terephthalic acid using a catalyst having a dicarboximide skeleton; hydrothermally treating the product with hot water, decomposing and removing catalyst impurities | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| US-20100331569-A1 | PROCESS FOR PRODUCTION OF OXYGEN-CONTAINING ORGANIC COMPOUND | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-30 | — | — | US | disclosed |
| US-7834217-B2 | Method for producing oxidation product of cycloalkane | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-11-16 | — | — | US | disclosed |
| EP-2248792-A1 | PROCESS FOR PRODUCTION OF OXYGEN-CONTAINING ORGANIC COMPOUND | Daicel Chemical Industries, Ltd. (JP) | 2010-11-10 | — | — | EP | disclosed |
| US-20100081848-A1 | METHOD FOR PRODUCING OXIDATION PRODUCT OF CYCLOALKANE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-04-01 | — | — | US | disclosed |
| US-20100029956-A1 | METHOD FOR PRODUCING ESTER OR LACTONE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| EP-2123646-A1 | METHOD FOR PRODUCING ESTER OR LACTONE | Daicel Chemical Industries, Ltd. (JP) | 2009-11-25 | — | — | EP | disclosed |
| US-7034184-B2 | Process for producing azine compounds and oxime compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-04-25 | — | — | US | disclosed |
| US-20060030716-A1 | Catalyst comprising cyclic acylurea compound and process for producing organic compounds using the catalyst | ISHII YASUTAKA | 2006-02-09 | — | — | US | disclosed |
| US-20050020439-A1 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2005-01-27 | — | — | US | disclosed |
| EP-1342714-B1 | Process for producing azine compounds and oxime compounds | DAICEL CHEM (JP) | 2005-01-26 | — | — | EP | disclosed |
| EP-1459804-A1 | CATALYSTS COMPRISING CYCLIC ACYLUREA COMPOUNDS AND PROCESSES FOR PRODUCTION OF ORGANIC COMPOUNDS WITH THE SAME | Daicel Chemical Industries, Ltd. (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-6768023-B2 | REACTING AN ESTER OR SALT OF NITROUS ACID WITH A COMPOUND THAT GENERATES A FREE RADICAL IN THE PRESENCE OF A NITROGEN CONTAINING CYCLIC COMPOUND CONTAINING AN N-OXY OR -HYDROXY IMIDE GROUP; FORMING OXIMES, NITRO COMPOUNDS, AND KETONES | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-07-27 | — | — | US | disclosed |
| US-20030204084-A1 | Process for producing azine compounds and oxime compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-10-30 | — | — | US | disclosed |
| US-20030171618-A1 | Process for producing organic compounds using nitrites | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-09-11 | — | — | US | disclosed |
| EP-1342715-A2 | Process for producing oximes using nitirites | Daicel Chemical Industries, Ltd. (JP) | 2003-09-10 | — | — | EP | disclosed |
| EP-1342714-A1 | Process for producing azine compounds and oxime compounds | Daicel Chemical Industries, Ltd. (JP) | 2003-09-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030204084-A1 | Process for producing azine compounds and oxime compounds | CBR1, DAO, ALKBH2 | KMT2A 1581/4885CRBN 429/4885BRD4 3393/4885 |
| US-20030171618-A1 | Process for producing organic compounds using nitrites | NOS1, NOS2, NOS3 | KMT2A 3719/4885CRBN 355/4885BRD4 4162/4885 |
| US-20100029956-A1 | METHOD FOR PRODUCING ESTER OR LACTONE | RIOX2, CBR1, AKR7A2 | KMT2A 3324/4885CRBN 1233/4885BRD4 2225/4885 |
| US-20100081848-A1 | METHOD FOR PRODUCING OXIDATION PRODUCT OF CYCLOALKANE | CBR3, CBR1, CYCS | KMT2A 4012/4885CRBN 2837/4885BRD4 4751/4885 |
| US-20100331569-A1 | PROCESS FOR PRODUCTION OF OXYGEN-CONTAINING ORGANIC COMPOUND | HAO2, SCO2, CYC1 | KMT2A 2843/4885CRBN 1630/4885BRD4 3580/4885 |
| US-20060030716-A1 | Catalyst comprising cyclic acylurea compound and process for producing organic compounds using the catalyst | MOGAT2, HAT1, ACOX1 | KMT2A 1306/4885CRBN 2979/4885BRD4 3479/4885 |
| US-20050020439-A1 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | MOGAT2, ACSS2, ACOX1 | KMT2A 1623/4885CRBN 2910/4885BRD4 3616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.